References
- Roser M, Ritchie H. Cancer. Published online at OurWroldInData. org. 2018. Available from: 'https://ourworldindata.org/cancer'
- de la Chapelle A. Genetic predisposition to colorectal cancer. Nat Rev Cancer 2004;4:769-80. https://doi.org/10.1038/nrc1453
- Gillen CD, Walmsley RS, Prior P, Andrews HA, Allan RN. Ulcerative colitis and Crohn's disease: a comparison of the colorectal cancer risk in extensive colitis. Gut 1994;35:1590-2. https://doi.org/10.1136/gut.35.11.1590
- Luongo C, Moser AR, Gledhill S, Dove WF. Loss of Apc (+) in Intestinal Adenomas from Min Mice. Cancer Research 1994;54:5947-52.
- Yamada Y, Mori H. Multistep carcinogenesis of the colon in Apc(Min/+) mouse. Cancer Sci 2007;98:6-10. https://doi.org/10.1111/j.1349-7006.2006.00348.x
- Amos-Landgraf JM, Kwong LN, Kendziorski CM, Reichelderfer M, Torrealba J, Weichert J, et al. A target-selected Apc-mutant rat kindred enhances the modeling of familial human colon cancer. Proc Natl Acad Sci U S A 2007;2104:4036-41.
- Johnson RL, Fleet JC. Animal models of colorectal cancer. Cnacre Metastasis Rev 2013;32:39-61. https://doi.org/10.1007/s10555-012-9404-6
- Irving AA, Yoshimi K, Hart ML, Parker T, Clipson L, Ford MR, et al. The utility of Apc-mutant rats in modeling human colon cancer. Dis Model Mech 2014;7:1215-25. https://doi.org/10.1242/dmm.016980
- Edelmann W, Yang F, Kuraguchi M, Heyer J, Lia M, Kneitz B, et al. Tumorigenesis in Mlh1 and Mlh1/Apc1638N mutant mice. Cancer Research 1999;59:1301-7.
- Reitmair AH, Redston M, Cai JC, Chuang TC, Bjerknes M, Cheng H, et al. Spontaneous intestinal carcinomas and skin neoplasms in Msh2-deficient mice. Cancer Res 1996;56:3842-9.
- Belcheva A, Irrazabal T, Robertson SJ, Streutker C, Maughan H, Rubino S, et al. Gut microbial metabolism drives transformation of MSH2-deficient colon epithelial cells. Cell 2014;158:288-99. https://doi.org/10.1016/j.cell.2014.04.051
- Yeo M, Surh YJ, Hahm KB. Molecular mechanism underlying the colitis-associated colorectal cancer. Korean J Med 2006;20:130-7. (Korean)
- Bansal P, Sonnenberg A. Risk factors of colorectal cancer in inflammatory bowel disease. Am J Gastroenterol 1996;91:44-8.
- Jass JR, Whitehall VL, Young J, Leggett BA. Emerging concepts in colorectal neoplasia. Gastroenterology 2002;123:862-76. https://doi.org/10.1053/gast.2002.35392
- Seril DN, Liao J, Yang GY, Yang CS. Oxidative stress and ulcerative colitis-associated carcinogenesis: studies in humans and animal models. Carcinogenesis 2002;24:353-62.
- Yamamoto Y, Gaynor RB. Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer. J Clin Invest 2001;107:135-42. https://doi.org/10.1172/JCI11914
- Yeo M, Kim DK, Park HJ, Oh TY, Kim JH, Cho SW, et al. Loss of transgelin in repeated bouts of ulcerative colitis-induced colon carcinogenesis. Proteomics 2006;6:1158-65. https://doi.org/10.1002/pmic.200500390
- Okayasu I, Yamada M, Mikami T, Yoshida T, Kanno J, Ohkusa T. Dysplasia and carcinoma development in a repeated dextran sulfate sodium-induced colitis model. J Gastroenterol Hepatol 2002;17:1078-83. https://doi.org/10.1046/j.1440-1746.2002.02853.x
- Tanaka T, Kohno H, Suzuki R, Yamada Y, Sugie S, Mori H. A novel inflammation-related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate. Cancer Sci 2003;94:965-73. https://doi.org/10.1111/j.1349-7006.2003.tb01386.x
- De Robertis M, Massi E, Poeta ML, Carotti S, Morini S, Cecchetelli L, et al. The AOM/DSS murine model for the study of colon carcinogenesis: From pathways to diagnosis and therapy studies. J Carcinog 2011;10:9. https://doi.org/10.4103/1477-3163.78279